John Szilagyi (left) is a Principal Scientist at Bristol Myers Squibb (NJ, USA), working in nonclinical development and investigative toxicology, with a focus on the development of models to study ...

Advanced 3D cell models recreate the complexity of human tissues, enabling researchers to examine tumor progression, probe neurological disorders, and assess therapeutic candidates. By capturing the ...

Inventia Life Science, an innovator in 3D cell culture technologies, announces the launch of RASTRUM™ Allegro, a groundbreaking advancement in 3D cell culture technology designed to accelerate drug ...

Scientists have successfully immortalized lip cells, allowing new treatments for injuries and infections to be trialed on a clinically relevant lab-based model We use our lips to talk, eat, drink, and ...

DUBLIN--(BUSINESS WIRE)--Inventia Life Science, a leading advanced cell model company, launched the Inventia Third Dimension Grant today. This grant will allow researchers studying fundamental biology ...

Most potential oncology drugs fail during the drug development pipeline, even when there has been promising data for their efficacy during the in vitro stage. This makes it vital to identify in vitro ...

Live-cell analysis and stem cell isolation techniques help researchers fully leverage 3D spheroid models, bridging the gap between in vitro findings and in vivo outcomes. When derived from isolated ...

The life science group Sartorius launches the new Incucyte® CX3 Live-Cell Analysis System, delivering the most advanced capabilities for 3D cell culture applications. Expanding the Incucyte® ...

Using a newly devised, three-dimensional model to study the regeneration of nerve tissue in the nose, researchers at Tufts University School of Medicine and the Graduate School of Biomedical Sciences ...